The group focuses on characterizing cellular immune responses that effectively control viral infections
VIRIEVAC combines virology, cellular immunology, and bioinformatics in the study of virus-immune interactions so as to understand the role played by T-cells in controlling HIV-1 and SARS-CoV-2 infections. Its ultimate goal is, by defining the functional features behind long-term effective cellular immunity against viral infections, to develop innovative immune monitoring tools and immune interventions.
-
-
-
Pathobiont-induced suppressive immune imprints thwart T cell vaccine responses.
SARS-CoV-2 Infection Risk by Vaccine Doses and Prior Infections Over 24 Months: ProHEpiC-19 Longitudinal Study.
Protein Nanoparticles for Targeted SARS-CoV-2 Trapping and Neutralization.
NSGS mice humanized with cord blood mononuclear cells show sustained and functional myeloid-lymphoid representation with limited graft-versus-host disease.
Multimodal neuroimaging in Long-COVID and its correlates with cognition 1.8 years after SARS-CoV-2 infection: a cross-sectional study of the Aliança ProHEpiC-19 Cognitiu
-
-
-
News from the group
